INGN INOGEN INC Management Changes 8-K Filing 2024 - Departure of Directors or Certain Officers Inogen Inc announces the departure of Dr. Stanislav Glezer, Executive Vice President, R&D and Chief Medical Officer, and the expectation of entering into a Separation Agreement with benefits consistent with his employment agreement.Get access to all SEC 8-K filings of the INOGEN INC